Ignite Immunotherapy has a total of 22 patents globally, out of which 3 have been granted. Of these 22 patents, more than 77% patents are active. The United States of America is where Ignite Immunotherapy has filed the maximum number of patents. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Ignite Immunotherapy.
Ignite Immunotherapy was founded in the year 2015. The company was created to find optimal gene and immunotherapy delivery vehicles to target cancer cells in a variety of patient populations with common metastatic tumor types. The company specializes in oncolytic virus design and development, cancer immunotherapy, gene therapy vector discovery, experimental cancer therapeutics, and biotech entrepreneurship.
Do read about some of the most popular patents of Ignite Immunotherapy which have been covered by us in this article and also you can find Ignite Immunotherapy patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ignite Immunotherapy patent portfolio.
How many patents does Ignite Immunotherapy have?
Ignite Immunotherapy has a total of 22 patents globally. These patents belong to 3 unique patent families. Out of 22 patents, 17 patents are active.
How Many Patents did Ignite Immunotherapy File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Ignite Immunotherapy Applications Filed | Ignite Immunotherapy Patents Granted |
| 2023 | 1 | 2 |
| 2022 | 2 | 1 |
| 2020 | 19 | – |
How many Ignite Immunotherapy patents are Alive/Dead?
Worldwide Patents
How Many Patents did Ignite Immunotherapy File in Different Countries?
Countries in which Ignite Immunotherapy Filed Patents
| Country | Patents |
| United States Of America | 3 |
| Taiwan | 2 |
| Canada | 2 |
| Europe | 2 |
| Argentina | 2 |
| Australia | 1 |
| Brazil | 1 |
| Russia | 1 |
| India | 1 |
| Hong Kong (S.A.R.) | 1 |
| Japan | 1 |
| Mexico | 1 |
| Israel | 1 |
Where are Research Centers of Ignite Immunotherapy Patents Located?
The Research Centre for all the Ignite Immunotherapy patents is the United States of America.
Best Ignite Immunotherapy Patents
WO2021116943A1 is the most popular patent in the Ignite Immunotherapy portfolio. It has received 1 citation so far from company like Hangzhou Arnold Biomedical Technology Co Ltd.
List of Ignite Immunotherapy Patents
| Ignite Immunotherapy Patents | Title |
| US11685904B2 | Recombinant Vaccinia Virus And Methods Of Use Thereof |
| US11529402B2 | Recombinant Vaccinia Virus And Methods Of Use Thereof |
| US20230002740A1 | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| EP4073088A1 | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| EP3923967A1 | Recombinant Vaccinia Virus And Methods Of Use Thereof |
| CA3163805A1 | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| CA3129883A1 | Recombinant Vaccinia Virus And Methods Of Use Thereof |
| AU2020402303A1 | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| JP2022520220A | Recombinant Vaccinia Virus And Method Of Use Thereof |
| HK40078852A | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| IN202217035312A | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| RU2805179C1 | Vaccine Oncolytic Version And Methods Of Its Use |
| AR122250A1 | Recombinant Vaccinia Virus And Methods Of Use Thereof |
| BR112022011158A2 | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| IL293627A | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| MX2022007237A | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof. |
| AR117808A1 | Recombinant Vaccine Virus And Methods Of Use Thereof |
| WO2021116943A1 | Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof |
| WO2020165730A1 | Recombinant Vaccinia Virus And Methods Of Use Thereof |
| WO2020148612A1 | Recombinant Vaccinia Virus And Methods Of Use Thereof |
| TW202102524A | Recombinant Vaccinia Virus And Methods Of Use Thereof |
| TW202038994A | Recombinant Vaccinia Virus And Methods Of Use Thereof |
What are Ignite Immunotherapy key innovation segments?
What Technologies are Covered by Ignite Immunotherapy?
The chart below distributes patents filed by Ignite Immunotherapy